ASCENTAGE
Live / Allowed — Published for opposition (as of 10 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 31 Mar 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99113144
- Mark type
- Design + words
- Filed
- 31 Mar 2025
- Published for opposition
- 10 Mar 2026
- Attorney of record
- Kathryn E. Smith
Goods and services
- Class 005 — Pharmaceuticals: Chemical preparations for medical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs sold in bulk, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; biochemical medicines for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; medicines for human purposes for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs for medical purposes in the nature of prescription apoptosis targeted compounds, next-generation kinase inhibitors and senolytic drugs; biological preparations for medical purposes, namely, biological preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemical preparations for pharmaceutical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; radioactive substances for medical purposes; gases for medical purposes, namely, nitric oxide for medical purposes; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; disinfectants; solutions for contact lenses; media for bacteriological cultures for medical purposes; medicated sweets; dietetic preparations adapted for medical purposes; depuratives for the body; diagnostic preparations for veterinary purposes; pesticides; sanitary napkins; cotton for medical purposes; dental abrasives; diapers for pets
Owner
- ASCENTAGE PHARMA (SUZHOU) CO., LTD., JIANGSU, CN
- ASCENTAGE PHARMA (SUZHOU) CO., LTD., JIANGSU, CN
Prior registrations
Prosecution history
- 10 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Mar 2026 — PUBLISHED FOR OPPOSITION
- 04 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Feb 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 12 Jan 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 12 Jan 2026 — LETTER OF SUSPENSION E-MAILED
- 12 Jan 2026 — SUSPENSION LETTER WRITTEN
- 05 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 10 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 10 Sept 2025 — NON-FINAL ACTION E-MAILED